Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds
Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence
Age Doesn’t Affect Survival After Bone Marrow Transplant
Lenalidomide Found Effective For Lymphoma In Phase II Trial
Intensive Chemo Equivalent To Transplant For MCL
Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant
Arzerra Promising For Heavily Pre-Treated CLL Patients
Dismissed Leukemia Drug Helps CLL, Clinical Trials Find
PDX Shows 27% Response In T-Cell Lymphoma In Study
Second-Generation CML Drugs Show Promise For Frontline
Gleevec To Prevent Recurrence Of Gastrointestinal Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies
